Tissue & Organ Applications
Tengion's technology platform has been applied to the following organs and tissue systems. Initially, the company will focus on urologic, renal, gastrointestinal, and vascular diseases and conditions.
 |
 |
 |
 |
|
 |
 |
 |
||
 |
 |
 |
||
 |
|
|
|
|
Featured Information
Latest News
- August 11, 2010: Tengion Provides Corporate and Product Development Update and Reports Second Quarter 2010 Financial Results
- August 4, 2010: Tengion Announces Second Quarter 2010 Results
- August 2, 2010: Tengion Appoints A. Brian Davis Chief Financial Officer
- July 7, 2010: Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
- June 17, 2010: Tengion Presents New Data Supporting its Organ Regeneration Platform(TM) at 8th Annual Meeting of the International Society for Stem Cell Research